Med Cort 6mg Tablet DEFLAZACORT

Introduction to Med Cort 6mg Tablet

Med Cort 6mg Tablet is a medication primarily used to treat conditions like Duchenne muscular dystrophy (DMD) in children aged 5 and older. It helps in reducing inflammation and suppressing the immune system to manage symptoms effectively.

Composition of Med Cort 6mg Tablet

The active ingredient in Med Cort 6mg Tablet is Deflazacort, which is a type of corticosteroid. It works by reducing inflammation and modifying the body's immune response.

Uses of Med Cort 6mg Tablet

• Management of Duchenne muscular dystrophy (DMD) in children
• Reduction of inflammation in various conditions
• Suppression of the immune system to prevent overactivity

Side effects of Med Cort 6mg Tablet

Common side effects:

• Weight gain
• Increased appetite
• Round face (Cushingoid appearance)
• Upper respiratory infections (common cold)
• Frequent urination
• Nose and throat inflammation
• Excessive hair growth
• Irritability

Serious side effects:

• Allergic reactions like rash, itching, or swelling
• Severe dizziness
• Trouble breathing

Precautions of Med Cort 6mg Tablet

Before taking Med Cort 6mg Tablet, inform your doctor if you are allergic to it or any of its ingredients. Use with caution during pregnancy and breastfeeding. Do not stop taking the medication suddenly, as it can lead to steroid withdrawal syndrome, causing symptoms like loss of appetite, nausea, vomiting, tiredness, and headache.

How to Take Med Cort 6mg Tablet

• Take the tablet once daily by mouth.
• The recommended dose is about 0.9 mg for each kilogram of body weight.
• It can be taken with or without food.
• Avoid taking it with grapefruit juice.

Conclusion of Med Cort 6mg Tablet

Med Cort 6mg Tablet is an effective medication for managing Duchenne muscular dystrophy and other inflammatory conditions. It is important to follow the prescribed dosage and take necessary precautions to avoid potential side effects. Always consult your healthcare provider for personalized advice and guidance.